Skip to content
Lifestyle & Learning

Archives of Dermatological Research Impact Factor: Analysis and Submission Guide

In this article

As of 2026, the Archives of Dermatological Research impact factor stands at approximately 2.4 to 3.0, maintaining its position as a reliable, mid-tier Q2 or Q3 journal within the Dermatology category. Published by Springer Nature, it remains one of the oldest and most respected venues for experimental and clinical dermatology research.

Introduction to Archives of Dermatological Research

Established in 1869, Archives of Dermatological Research (formerly known as Archiv für Dermatologie und Syphilis) holds a distinguished place in the history of medical publishing. For over 150 years, it has served as a bridge between basic science and clinical application. While many newer journals focus exclusively on high-impact clinical trials or narrow molecular biology, this journal prides itself on a broad scope that encompasses the morphology, physiology, and pathology of the skin.

In the academic landscape of 2026, the impact factor (IF) remains a primary metric for researchers evaluating where to submit their work. However, the impact factor is only one piece of the puzzle. To truly understand the value of the Archives of Dermatological Research (ADR), one must look at its citation longevity, its editorial rigor, and its specific niche within the global dermatological community.

Defining the Impact Factor and Its Calculation

The Journal Impact Factor (JIF) is a metric calculated by Clarivate and published annually in the Journal Citation Reports (JCR). It is designed to represent the average number of citations received by articles published in the journal over the preceding two years.

For a researcher in 2026, the calculation for the ADR impact factor would look like this:

  1. Numerator: The number of citations received in 2025 to articles published in ADR in 2023 and 2024.
  2. Denominator: The total number of "citable items" (mostly original research articles and reviews) published in ADR in 2023 and 2024.

A score in the 2.4 to 3.0 range indicates that, on average, each article published in the journal is cited between two and three times within the first two years of its publication. While this is lower than "top-tier" journals like the Journal of the American Academy of Dermatology (JAAD), it reflects a steady, specialized audience of academic researchers rather than a mass-market clinical audience.

Nature Photonics Impact Factor 2025 - Journal Impact Factor
Nature Photonics Impact Factor 2025 - Journal Impact Factor

Performance Metrics and Rankings in 2026

While the Impact Factor is the most recognized metric, Springer and other indexing services provide several other data points that help researchers gauge the journal's prestige and reach.

CiteScore (Scopus)

The CiteScore, provided by Elsevier’s Scopus database, often trends higher than the JCR Impact Factor because it uses a four-year window instead of two. As of early 2026, the ADR CiteScore is approximately 4.5 to 5.2. This indicates that ADR articles continue to be cited well beyond the initial two-year window, suggesting that the research published here has a longer "shelf-life" than average.

SCImago Journal Rank (SJR)

The SJR accounts for both the number of citations and the prestige of the journals where those citations originate. ADR typically resides in the Second Quartile (Q2) or Third Quartile (Q3). This ranking confirms that it is an established, reputable journal that is respected by peers, even if it does not reach the astronomical citation counts of "high-impact" general medicine journals.

Source Normalized Impact per Paper (SNIP)

SNIP adjusts for differences in citation practices between scientific fields. Because dermatology is a smaller field than oncology or cardiology, a raw impact factor of 2.6 might be more impressive than it looks. The SNIP for ADR helps contextualize this, usually showing that the journal performs strongly relative to other experimental dermatology publications.

Comparison with Other Dermatology Journals

To understand where Archives of Dermatological Research fits into your publication strategy, it is helpful to compare its metrics with other major titles in the field.

Journal Name Impact Factor (Approx. 2025/26) Primary Focus Best For
Journal of Investigative Dermatology (JID) 7.0 - 8.5 Molecular/Cellular Biology High-level basic science
JAAD 13.0 - 15.0 Clinical Practice/Guidelines Major clinical trials
British Journal of Dermatology (BJD) 10.0 - 11.5 Clinical/Experimental Mix Prestigious European reach
Archives of Dermatological Research (ADR) 2.4 - 3.0 Experimental/Clinical Specialized academic research
Dermatology (Karger) 4.0 - 5.0 Clinical/Therapeutic Rapid clinical updates
JEADV 9.0 - 10.0 Clinical/Venereology European clinical practice

The table illustrates that ADR serves a specific niche. It is a "workhorse" journal for academic dermatology. If your research is technically sound and provides meaningful insights into skin physiology but lacks the revolutionary "breakthrough" status required for JID or Nature Communications, ADR is an excellent target.

Why the ADR Impact Factor Matters for Your Career

For many academics, the impact factor of the journals in which they publish is tied directly to career progression, including tenure, promotions, and grant eligibility.

Grant Applications and Funding

Funding bodies, such as the NIH (USA) or the ERC (Europe), look for a track record of publication in indexed, peer-reviewed journals. Publishing in a journal with an impact factor above 2.0 signifies that your work is part of the global scientific conversation. While a 2.6 IF may not carry the same weight as a 10.0, it demonstrates consistency and quality, which are often more important for early-career researchers than a single "lucky" high-impact paper.

Institutional Requirements

Many universities have "Points Systems" for faculty evaluations. Often, journals in the Q2/Q3 range provide a solid baseline of points. Because ADR is a Springer journal, it is automatically indexed in PubMed/MEDLINE, Web of Science, and Scopus, ensuring your work is discoverable by researchers worldwide.

The Value of the Springer "Open Choice"

ADR offers an Open Choice (hybrid) model. This allows authors to pay an Article Processing Charge (APC) to make their paper Open Access. Studies have shown that Open Access papers generally receive more citations than those behind a paywall. If you are concerned about maximizing your personal citation count or the journal's future impact factor, opting for Open Access is a strategic move.

Editorial Scope and Submission Categories

The Archives of Dermatological Research is interested in "the whole spectrum of dermatological research." This is broader than many competitors. In 2026, the journal particularly emphasizes the following areas:

  • Clinical Investigation: High-quality studies on patient cohorts, provided they include some level of mechanistic insight.
  • Experimental Dermatology: Studies involving in-vitro models, skin equivalents, and animal models that explain how the skin functions or reacts to disease.
  • Molecular and Cell Biology: Research into the genetic and proteomic underpinnings of skin disorders like psoriasis, atopic dermatitis, and melanoma.
  • Immunology: The skin's immune system remains a top priority, especially research into biological therapies and their pathways.

Submission Types

  1. Original Papers: These are full-length research reports. They typically require a rigorous methodology and substantial data.
  2. Short Communications: For researchers with a single, compelling finding that doesn't require a full-length treatment. These are often published faster.
  3. Reviews: The journal occasionally publishes comprehensive literature reviews. Note that these are highly cited and significantly contribute to the journal's impact factor.
  4. Letters to the Editor: Usually focused on commenting on previously published work or very brief clinical observations.

The Peer Review Process and Publication Speed

In the current academic climate of 2026, the speed of publication is often as important as the impact factor. Archives of Dermatological Research utilizes the Editorial Manager system, providing a streamlined experience for authors.

  • Time to First Decision: Historically, ADR provides a first decision in roughly 30 to 50 days. This is relatively fast compared to many clinical journals that can take several months.
  • Review Rigor: The journal typically employs at least two independent peer reviewers. They look for scientific validity, ethical compliance, and clarity of language.
  • Online First: Once accepted, papers are usually published online within 2-3 weeks. This "Online First" version is fully citable with a DOI, meaning your work starts gathering potential citations long before it appears in a print volume.

Submission Guidelines and Best Practices

To successfully publish in ADR and contribute to its impact factor, you must adhere to high technical standards.

1. Abstract Structure

Ensure your abstract is concise and informative. It should clearly state the Background, Methods, Results, and Conclusion. Since many citation databases only index the abstract, this is your primary tool for attracting readers and citations.

2. Ethical Standards

ADR requires strict adherence to ethical guidelines. This includes:

  • Institutional Review Board (IRB) Approval: For any research involving human subjects.
  • Animal Welfare Statements: For research involving animal models.
  • Conflict of Interest Disclosure: All authors must declare any financial or personal relationships that could influence the work.

3. Data Presentation

High-quality figures are essential. Springer recommends figures be submitted in TIFF or EPS format with a minimum resolution of 300 DPI. Clear, well-labeled charts and high-resolution histology slides significantly improve the chances of acceptance and subsequent citation.

Future Outlook for ADR in 2026 and Beyond

The trend for Archives of Dermatological Research is one of stability. While it is unlikely to jump to an impact factor of 10.0—due to its commitment to experimental dermatology rather than broad clinical trials—it is also unlikely to lose its relevance.

The journal is increasingly incorporating digital innovations, such as Graphical Abstracts and Video Abstracts, to increase engagement. As more researchers from emerging scientific hubs in Asia and South America look for reputable, historically established journals, ADR is poised to maintain or slightly increase its citation metrics over the coming years.

FAQs

What was the impact factor of Archives of Dermatological Research in 2024 and 2025?

In 2024 and 2025, the impact factor fluctuated between 2.4 and 2.8. These fluctuations are common in mid-sized journals and often depend on the number of "highly cited" review articles published in the prior two-year window. The 2026 metrics show a continued trajectory of steady growth.

Is Archives of Dermatological Research a Q1 journal?

Generally, no. In the "Dermatology" category of the Journal Citation Reports (JCR), ADR usually falls into the Q2 (Second Quartile) or Q3 (Third Quartile). Q1 journals are typically reserved for the top 25% of journals by impact factor, which in dermatology requires a score of roughly 6.0 or higher.

Does the journal charge for publication?

ADR is a "Hybrid" journal. This means you can choose to publish for free under the traditional subscription model (where libraries pay for access). Alternatively, you can pay an Article Processing Charge (APC) for Open Access publication. As of 2026, Springer's standard APC for dermatology journals is approximately $3,000 to $4,000, though this varies by region and institutional agreements.

How long does it take from submission to publication?

Most authors receive a first decision within about 6 weeks. If revisions are required, the total time from submission to the final "Online First" publication typically ranges from 4 to 6 months. This is considered efficient for a high-quality peer-reviewed journal.

Why is the CiteScore different from the Impact Factor?

CiteScore is calculated by Scopus and uses a different time window (4 years) and a broader range of document types. The Impact Factor is calculated by Clarivate (JCR) and uses a 2-year window. CiteScore usually provides a better view of "long-term" impact, whereas the Impact Factor is a "snapshot" of recent citations.

Final Recommendation

If you are a researcher in 2026 looking for a journal that offers a blend of historical prestige, rigorous peer review, and a focus on the fundamental science of the skin, Archives of Dermatological Research is a highly recommended choice. While its impact factor of 2.4–3.0 may not be the highest in the field, its inclusion in major databases like PubMed and its association with a powerhouse publisher like Springer Nature ensure your research will be seen, cited, and respected by the global dermatological community.

Researchers should focus on ADR when they have solid, mechanistic studies that contribute to our understanding of dermatological diseases, even if the research doesn't fit the "high-stakes" criteria of top-decile clinical journals.

Professional Advice Limitation: This article is for informational and academic purposes. Impact factors and journal metrics are subject to annual change. Always verify the most recent data on the official Springer Nature or Journal Citation Reports (JCR) websites before making final submission decisions. This content does not constitute medical or professional career advice.